Works matching IS 02780232 AND DT 2025 AND VI 43 AND IP 1
Results: 32
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70033
- By:
- Publication type:
- Article
One‐Day Brentuximab–Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70031
- By:
- Publication type:
- Article
MicroRNA Profiling of Bone Marrow Plasma Extracellular Vesicles in Multiple Myeloma, Extramedullary Disease, and Plasma Cell Leukemia.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70036
- By:
- Publication type:
- Article
Clinical Impact of Osteolytic Bone Lesions in POEMS Syndrome: A Single‐Center Experience of 114 Patients.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70037
- By:
- Publication type:
- Article
Correction to Elotuzumab Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Extended Follow‐Up of a Multicenter, Retrospective Real‐World Experience With 321 Cases Outside of Controlled Clinical Trials.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70039
- Publication type:
- Article
Comprehensive Characterization of Overt Myelofibrosis in an Asian Cohort: Phenotype, Mutation Landscape and Discordance Among Scoring Systems.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70040
- By:
- Publication type:
- Article
Successful Pregnancies During Crizotinib Therapy for Anaplastic Lymphoma Kinase Positive Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70038
- By:
- Publication type:
- Article
The Role of 24‐Month Progression‐Free Survival (PFS24) in the Long‐Term Evaluation of Patients With Diffuse Large B Cell Lymphoma (DLBCL): A Real‐World Single Center Study.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70034
- By:
- Publication type:
- Article
Childhood ALL and Asparaginase Intensification: Are We at the Brink?
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70032
- By:
- Publication type:
- Article
Impact of C‐MYC/BCL2 Double Expression on Survival Outcomes After Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma—A Nationwide Retrospective Analysis in Singapore.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70030
- By:
- Publication type:
- Article
Baseline Tumor Burden Assessed With AI‐Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR‐T in Aggressive B‐Cell Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70029
- By:
- Publication type:
- Article
Implications of Genetic, Biological and Clinical Parameters in Patients With Richter Syndrome: A Monocentric Experience.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70028
- By:
- Publication type:
- Article
Long‐Term Outcomes of Reduced‐Toxicity Conditioning Using 8‐Gray Total Body Irradiation, Fludarabine, and Cyclophosphamide in Children, Adolescents, and Young Adults With Hematological Malignancies.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70026
- By:
- Publication type:
- Article
Post‐CAR T‐Cell Therapy Failure Metabolic Parameters Predict Survival and Response in Large B‐Cell Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70025
- By:
- Publication type:
- Article
Lifetime Treatment Trajectories of Mantle Cell Lymphoma: Simulation Based Analysis of 20 Years of Real‐World Data.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70024
- By:
- Publication type:
- Article
Hospital Palliative Care Team Consultations in Different Subgroups of Hematologic Malignancies.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70021
- By:
- Publication type:
- Article
In Situ Tracking of TCRβ Isoforms for Detection of T Cell Clonality: Implication for Precision Diagnosis and Targeted Immunotherapy of T‐Cell Neoplasms.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70018
- By:
- Publication type:
- Article
Efficacy and Safety of Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin and Prednisone for Previously Untreated Diffuse Large B‐Cell Lymphoma: A Real‐World, Multi‐Center, Retrospective Cohort Study.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70017
- By:
- Publication type:
- Article
Ceiling Effect of International Myeloma Working Group Frailty Score in Real‐World Population of Older Adults With Cancer.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70016
- By:
- Publication type:
- Article
Breaking Traditions: Evaluating Single Fraction Radiation in Indolent Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70015
- By:
- Publication type:
- Article
Prognostic Role of Pretreatment Tumor Burden and Dissemination Features From 2‐[<sup>18</sup>F]FDG PET/CT in Advanced Mantle Cell Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70009
- By:
- Publication type:
- Article
Hypogammaglobulinemia at Diagnosis is Associated With Inferior Survival and Higher Risk of Infections in Diffuse Large B Cell Lymphoma.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70014
- By:
- Publication type:
- Article
Different Role of PET‐CT Evaluation in Newly Diagnosed Follicular Lymphoma Upon Rituximab‐Based Chemotherapy and Chemo‐Free Immunotherapy.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70012
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70011
- Publication type:
- Article
Combining Total Metabolic Tumor Volume With Beta‐2‐Microglobulin Levels Predicts Outcomes in High‐Burden Follicular Lymphoma Patients.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70010
- By:
- Publication type:
- Article
Molecular Profiling Identifies CD49d and CD79b as Predictive Markers for Acquired Acalabrutinib Resistance in Patients With Chronic Lymphocytic Leukemia.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70008
- By:
- Publication type:
- Article
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1‐Positive and ‐Negative Myeloproliferative Neoplasms.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70013
- By:
- Publication type:
- Article
Clinicopathological Characteristics of Extranodal Marginal Zone Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT‐Lymphoma) of the Intestine: A Single Center Analysis.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70007
- By:
- Publication type:
- Article
Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
- By:
- Publication type:
- Article
Comparing Outcomes Between CPX‐351 and Fludarabine‐Based Induction in Secondary Acute Myeloid Leukemia in the Real‐World Setting: The Prognostic Role of Measurable Residual Disease.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70005
- By:
- Publication type:
- Article
PET2‐Adapted Therapy in Patients With Advanced‐Stage Hodgkin Lymphoma Treated With Frontline ABVD: Searching for the Baby in the Bathwater.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70004
- By:
- Publication type:
- Article
Safety and Efficacy of Tinostamustine in a Subpopulation of Patients With Relapsed/Refractory Hodgkin Lymphoma From a Phase I Trial.
- Published in:
- Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70000
- By:
- Publication type:
- Article